Suppr超能文献

关于SK&F 29661对肾上腺儿茶酚胺长期影响的研究。

Studies on the long term effects of SK&F 29661 upon adrenal catecholamines.

作者信息

Pendleton R G, Gessner G, Sawyer J, Hillegass L, Miller D A

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1982 Apr;319(1):22-8. doi: 10.1007/BF00491473.

Abstract

SK&F 29661 (1,2,3,4-tetrahydro-7-isoquinoline-sulfonamide) is a potent and selective in vitro and in vivo inhibitor of adrenal phenylethanolamine N-methyltransferase (PNMT; EC 2.1.1.28). Its Ki value for in vitro inhibition of rat adrenal PNMT was 133 nM. In vivo, the adrenal conversion of 3H-norepinephrine to 3H-epinephrine was maximally inhibited by a single oral dose of 100 mg/kg. In long term chronic studies in rats, adrenal epinephrine was reduced by SK&F 29661 in a dose dependent fashion to greater than 90%, without substantial increases in norepinephrine. Urinary excretion of epinephrine was significantly reduced by the drug both basally and following 2-deoxy-D-glucose stimulation. No drug related changes were found in plasma corticosterone values and only small effects were observed on adrenal tyrosine hydroxylase and PNMT enzyme levels. The cardiac norepinephrine pool and its turnover time were both significantly reduced; its turnover rate, however, was only slightly increased. Our studies indicate that SK&F 29661 is a highly effective, non-toxic and novel pharmacological tool which is useful in depleting adrenal epinephrine stores via inhibition of its biosynthesis.

摘要

SK&F 29661(1,2,3,4-四氢-7-异喹啉磺酰胺)是一种在体外和体内均具有强效且选择性的肾上腺苯乙醇胺N-甲基转移酶(PNMT;EC 2.1.1.28)抑制剂。其对大鼠肾上腺PNMT体外抑制的Ki值为133 nM。在体内,单次口服100 mg/kg剂量可最大程度抑制3H-去甲肾上腺素向3H-肾上腺素的肾上腺转化。在大鼠的长期慢性研究中,SK&F 29661可使肾上腺肾上腺素以剂量依赖性方式减少至90%以上,而去甲肾上腺素无显著增加。该药物在基础状态以及2-脱氧-D-葡萄糖刺激后均显著降低肾上腺素的尿排泄。血浆皮质酮值未发现与药物相关的变化,对肾上腺酪氨酸羟化酶和PNMT酶水平仅观察到微小影响。心脏去甲肾上腺素池及其周转时间均显著缩短;然而,其周转率仅略有增加。我们的研究表明,SK&F 29661是一种高效、无毒且新颖的药理学工具,可通过抑制其生物合成来有效消耗肾上腺肾上腺素储备。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验